Discover 955 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 955
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Portland OR, Reno NV, Sacramento CA, Vallejo CA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase 3, Recruiting
Active & Responsive
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
for
Myasthenia Gravis, Myasthenia Gravis, MuSK
Location: Portland OR, Irvine CA, Aurora CO, Columbia MO,
Sponsor: NMD Pharma A/S
Sex: All
Age: 18+
Code: NCT06414954
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
for
Alzheimer's Disease
Location: Portland OR, Richmond, Kelowna, Redlands CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 60 - 70+
Code: NCT06976216
Phase 3, Recruiting
Active & Responsive
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Portland OR, San Francisco CA, Draper UT, Orem UT,
Sponsor: Reunion Neuroscience Inc
Sex: All
Age: 18 - 70+
Code: NCT07489651
Phase 2, Recruiting
Active & Responsive
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Location: Portland OR, Burien WA, Surrey, Vancouver, Lancaster CA,
Sponsor: Inmagene LLC
Sex: All
Age: 18 - 70+
Code: NCT07037901
Phase 2, Recruiting
Active & Responsive
TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)
for
Alcohol Use Disorder, Opioid Use Disorder
Location: Portland OR
Sponsor: Washington State University
Sex: All
Age: 18+
Code: NCT07171359
Recruiting
Active & Responsive
A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease
for
Still´s Disease
Location: Portland OR, Salt Lake City UT, Toronto
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 1+
Code: NCT07203001
Phase 2, Recruiting
Active & Responsive
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
for
Endometrial Cancer
Location: Portland OR, Eugene OR, San Francisco CA, La Jolla CA,
Sponsor: Faeth Therapeutics
Sex: Female
Age: 18+
Code: NCT06463028
Phase 2, Recruiting
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Portland OR, Vancouver WA, Seattle WA, Edmonds WA,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase 2, Phase 3, Recruiting
Active & Responsive
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
for
Multiple Myeloma in Relapse, Myeloma Multiple,
Location: Portland OR, San Francisco CA, Palo Alto CA, Duarte CA,
Sponsor: Kelonia Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07075185
Phase 1, Recruiting
Active & Responsive
CAN1012 in Pre-Malignant DCIS and LCIS
for
Ductal Carcinoma in Situ, Lobular Carcinoma in Situ
Location: Portland OR
Sponsor: Providence Health & Services
Sex: All
Age: 18+
Code: NCT07408856
Phase 1, Recruiting
Active & Responsive
ASSESS ALL ALS Study
for
Amyotrophic Lateral Sclerosis
Location: Portland OR, Seattle WA, Boise ID, San Francisco CA,
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix